| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03444649 Details | 2018-09-11 Interventional | 1 | 0 | Cytarabine Daunorubicin Idarubicin AML | IMP will not be further developed - | |||
| NCT01591902 Details | 2018-09-11 Interventional | 4 | 129 | Tesamorelin Diabetic Retino… Retinal Disease… HIV | - - | |||
| NCT00689390 2006-006529-25 Details | 2018-09-11 Interventional | 2/3 | 1954 | Peginterferon a… Ribavirin Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Hepacivirus | The study was terminated due to satisfaction of post-marketing commitments - | |||
| NCT00621530 Details | 2018-09-11 Interventional | 2 | 62 | Ketorolac Ketorolac Trome… Hypersensitivit… Hip Arthroplast… | Terminated due to discontinuation of Acular PF (investigational medication) The trial was terminated because the study drug became unavailable. | |||
| NCT02492763 Details | 2018-09-10 Interventional | 2 | 176 | Liraglutide Metformin Diabetes Mellit… Diabetes Mellit… Type II Diabete… | - - | |||
| NCT02489500 Details | 2018-09-10 Interventional | 3 | 3 | Bortezomib Lenograstim Melphalan Amyloidosis Immunoglobulin … AL Amyloidosis | Enrollment held for toxicity evaluation; then closed due to competing trial Early termination after enrollment held for toxicity evaluation; then closed due to competing trial. | |||
| NCT02181387 Details | 2018-09-10 Interventional | 4 | 33 | Acetaminophen Pain | funding and compounding issues - | |||
| NCT02143141 Details | 2018-09-10 Interventional | 4 | 13 | Morphine Pain, Postopera… Postoperative P… Scheduled Cesar… Side Effects | feasibility of population needed to complete study Early termination leading to small number of subjects analyzed. Extreme difficulty in recruiting participants to participate in the study. | |||
| NCT02131272 2013-005500-33 Details | 2018-09-10 Interventional | 3 | [1 Refs] | 42 | Insulin Insulin Detemir Insulin, Globin… Insulin, Isopha… Isophane Insuli… Isophane insuli… Diabetes Mellit… Diabetes Mellit… Diabetes | - The trial was terminated earlier than planned due to a very slow recruitment rate. Based on the low number of subjects, the conclusions should be interpreted with caution. | ||
| NCT01863667 2013-000301-23 Details | 2018-09-10 Interventional | 3 | 65 | Glimepiride Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | - The study was terminated based on business decisions only, and not due to any unexpected safety or efficacy concerns. | |||
| NCT00868790 Details | 2018-09-10 Interventional | 2 | 118 | Metformin Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | Upon interim analysis, sufficient data was accrued to assess study hypotheses. A pre-specified interim analysis of the efficacy and safety data for the initial cohort of participants in this study (Cohort 1) determined that sufficient data had been accrued to assess the study hypotheses, thus the study was discontinued. | |||
| NCT00322881 Details | 2018-09-10 Interventional | 2 | [1 Refs] | 12 | Carboplatin Paclitaxel Fallopian Tube … Mixed Tumor, Me… Fallopian Tube … Ovarian Cancer Primary Periton… | Early closure based on audit by study investigators after 3 patients died on study. This study terminated early due to 3 deaths on study and consequently results are limited. | ||
| NCT00693160 Details | 2018-09-07 Interventional | 2 | 30 | Capsaicin Ketorolac Remifentanil Healthy | the manufacturing of preservative free ketorolac (Acular-PF) was discontinued - | |||
| NCT00783172 Details | 2018-09-06 Interventional | 1 | 4 | Enkephalins Gemcitabine Mitogens Pancreatic Neop… Pancreatic Canc… | Problems with IRB - | |||
| NCT02757287 Details | 2018-09-05 Interventional | 4 | 0 | Desogestrel Infertility | Lack of financial support - | |||
| NCT02650635 Details | 2018-09-05 Interventional | 1 | 4 | Cyclophosphamid… Lenograstim Adenocarcinoma Breast Neoplasm… Carcinoma Carcinoma, Non-… Carcinoma, Rena… Colorectal Neop… Melanoma Melanoma, Cutan… Pancreatic Neop… Recurrence Colorectal Aden… Metastatic Panc… Recurrent Breas… Recurrent Color… Recurrent Melan… Recurrent Non-S… Recurrent Pancr… Recurrent Renal… Solid Neoplasm Stage IV Breast… Stage IV Non-Sm… Stage IV Renal … Stage IV Skin M… Stage IVA Color… Stage IVA Pancr… Stage IVB Color… Stage IVB Pancr… | permanently closed per sponsor's request - | |||
| NCT02093221 Details | 2018-09-05 Interventional | 2 | 76 | Alpha 1-Antitry… Protease Inhibi… Protein C Inhib… Alpha 1-Antitry… Diabetes Mellit… Diabetes Mellit… Type 1 Diabetes… | Wk 52 primary endpoint results would be unaffected by follow-up data so trial was discontinued
prior to wk 104. No safety data was collected after wk 52. - | |||
| NCT01104662 Details | 2018-09-05 Interventional | 4 | 92 | Cloxacillin Daptomycin Nafcillin Oxacillin Penicillins Vancomycin Bacteremia Communicable Di… Infections Renal Insuffici… Skin Diseases, … Complicated Ski… Renal Impairmen… S. Aureus Bacte… | Cubist has reached an agreement with the FDA that enrollment in the DAP-RENSE-08-05 study can
stop. - | |||
| NCT00039091 Details | 2018-09-05 Interventional | 1 | 26 | Antibodies Antibodies, Mon… Antineoplastic … Immunoglobulins Ipilimumab Carcinoma, Non-… Carcinoma, Ovar… Leukemia Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Lung Neoplasms Melanoma Myelodysplastic… Myelodysplastic… Myeloproliferat… Preleukemia Recurrence Syndrome Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Atypical Chroni… Myelodysplastic… Previously Trea… Recurrent Adult… Recurrent Melan… Recurrent Non-s… Recurrent Ovari… Stage IV Melano… Stage IV Non-sm… | - - | |||
| NCT03082300 Details | 2018-08-31 Interventional | 1 | 3 | Naquotinib Carcinoma, Non-… Lung Neoplasms Epidermal Growt… Non-small Cell … | Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies. - |